Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy-Reference-Cited by-同舟云学术

Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy

Published:2017-10-20 Issue:1 Volume:36 Page:166-173
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Kawamoto Keisuke¹²^ORCID,Miyoshi Hiroaki²,Suzuki Takaharu¹,Sasaki Yuya²,Yamada Kyohei²,Yanagida Eriko²,Muto Reiji²,Kiryu Maiko¹,Sone Hirohito¹,Seto Masao²,Ohshima Koichi²,Takizawa Jun¹

Affiliation:

1. Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine; Niigata University; Niigata Japan

2. Department of Pathology; Kurume University School of Medicine; Kurume Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference35 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

3. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years;Au;Ann Oncol,2005

4. Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211;Yamaguchi;J Clin Oncol,2012

5. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211;Yamaguchi;J Clin Oncol,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma;Chinese Medical Journal;2024-08-23

2. Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma;American Journal of Clinical Pathology;2024-02-22

3. EBV-positive Nodal T-Cell and NK-Cell Lymphoma;American Journal of Surgical Pathology;2024-01-30

4. Extranodal NK/T-Cell Lymphoma Predominantly Composed of Anaplastic Cells;American Journal of Surgical Pathology;2023-11-20

5. Novel target and treatment agents for natural killer/T-cell lymphoma;Journal of Hematology & Oncology;2023-07-22